Global Orthobiologics Market Size & Share to 2027

Orthobiologics is also called as regenerative cellular therapies. These are used by orthopedic surgeons to help injuries heal more quickly. There are various types of orthobiologics available in the market which relay on different mechanism of actions. These substances are used in higher concentration for accelerating healing processes.

Market Drivers

Rise in prevalence of sport injuries and a road accident is the key driving factor which is expected to boost the global orthobiologics market growth. Furthermore, increase in incidences of spinal disorders will positively contribute the market growth. Also, increase in research and development investments and collaborations by medical devices and biotechnology companies are expected to propel the global orthobiologics market growth. Moreover, increase in aging population as well as obese people will drive the market growth. In addition to that, rise in demand for minimally invasive procedures are expected to fuel the market growth in near future. The rise in government initiatives and funds will support the market growth during this forecast period.

Market Restraints

However, high cost associated with orthobiologics-based treatments is the major challenging factor which is expected to hinder the global orthobiologics market growth. Also, lack of reimbursement as well as stringent approval processes will affect the market growth during this analysis period.

Market Segmentation

Global Orthobiologics Market is segmented into product such as Demineralized Bone Matrix, Allograft, Bone Morphogenetic Protein, Viscosupplementation Products, Synthetic Bone Substitutes, and others, by type such as Ankle, Knee, Hip, Wrist & Shoulder, Spine, and Others. Further, market is segmented into end user such as Hospitals & Ambulatory Centers, Research & Academic Institutes, and Dental Clinics.

Also, Global Orthobiologics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as Medtronic PLC, Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., Harvest Technologies Corporation, Globus Medical, Inc, Orthofix International N.V., RTI Surgical, Inc., K2M Group Holdings, Inc., and Kuros Biosciences Ltd.

Market Taxonomy

By Product

• Demineralized Bone Matrix
• Allograft
• Bone Morphogenetic Protein
• Viscosupplementation Products
• Synthetic Bone Substitutes
• Others

By Type

• Ankle
• Knee
• Hip
• Wrist & Shoulder
• Spine
• Others

By End user

• Hospitals & Ambulatory Centers
• Research & Academic Institutes
• Dental Clinics

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Key Questions Addressed by the Report

• What are the Key Opportunities in Global Orthobiologics Market?
• What will be the growth rate from 2019 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?